Hepta

Detect, Monitor, and Enable Effective Treatment for Metabolic Disease

San Francisco, United States · Founded 2024 · $7.0M raised

Employees
1–10
Founded
2024
Business Model
B2B
Website
hepta.bio
Total Funding
$7.0M
Last Round
$6.7M SeedNov 2025
Rounds
2

About

Hepta is an AI-native liquid biopsy company focused on non-invasive diagnostics for metabolic liver disease. Its platform interprets epigenetic patterns in cell-free DNA from a standard blood draw to reveal liver biology, enabling earlier detection and treatment of MASH (metabolic dysfunction-associated steatohepatitis). Founded by former Illumina, GRAIL, and Google leaders, Hepta is headquartered in San Francisco.

Summary

Hepta is a Healthcare company based in San Francisco, United States, founded in 2024. It has raised $7.0M in total across 2 rounds, most recently a $6.7M Seed round in Nov 2025. Investors include Felicis Ventures, Illumina Ventures and Contrarian Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

SeedSeed (Recent)Nov 2025
$6.7M

Sign up to see all 2 rounds

Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hepta on Indexed.vc
<a href="https://indexed.vc/companies/hepta"><img src="https://indexed.vc/api/badge/company/hepta" alt="Hepta on Indexed.vc" width="260" height="76" /></a>